MTOR and hepatocellular carcinoma: Hyperinsulinemia and increased IGF receptor activation lead to the phosphorylation of IRS-1, triggering the activation of multiple cytokine pathways, including the PI3 K/AKT/mTOR and MAPK cascades, which regulate the cell cycle and may potentially enhance tumor progression in HCC (98).